Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 30 entries
View as:

A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00350636 Org: User:
Start: 06/30/06 End: 05/31/07 Due: 05/31/08

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00224107 Org: User:
Start: 05/31/05 End: 08/31/06 Due: 08/31/07

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00223964 Org: User:
Start: 06/30/03 End: - Due: -

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00224068 Org: User:
Start: 05/31/02 End: 12/31/03 Due: 12/31/04

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00793819 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00740779 Org: User:
Start: 09/30/08 End: 10/31/09 Due: 10/31/10

Pharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems

Phase: N/A Priority: Normal
NCT ID: NCT01323140 Org: User:
Start: 04/30/11 End: 07/31/11 Due: 07/31/12

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00752141 Org: User:
Start: 09/30/08 End: - Due: -

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Phase: N/A Priority: Normal
NCT ID: NCT01140217 Org: User:
Start: 05/31/10 End: 03/31/12 Due: 03/31/13

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

Phase: N/A Priority: Normal
NCT ID: NCT00224042 Org: User:
Start: 04/30/03 End: - Due: -

DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)

Phase: N/A Priority: Normal
NCT ID: NCT00224081 Org: User:
Start: 09/30/04 End: - Due: -

Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00224003 Org: User:
Start: 04/30/03 End: 02/28/05 Due: 02/28/06

A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition

Phase: N/A Priority: Normal
NCT ID: NCT00224029 Org: User:
Start: 12/31/04 End: 05/31/08 Due: 05/31/09

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00224055 Org: User:
Start: 04/30/03 End: 09/30/04 Due: 09/30/05

Effects of Oxybutynin Topical Gel on Gastric Emptying

Phase: N/A Priority: Normal
NCT ID: NCT00926926 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition

Phase: N/A Priority: Normal
NCT ID: NCT00224016 Org: User:
Start: 12/31/04 End: 09/30/08 Due: 09/30/09

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00527917 Org: User:
Start: 09/30/07 End: 09/30/08 Due: 09/30/09

Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Phase: N/A Priority: Normal
NCT ID: NCT01553123 Org: User:
Start: 04/30/12 End: 12/31/13 Due: 12/31/14

The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months

Phase: N/A Priority: Normal
NCT ID: NCT00224133 Org: User:
Start: 09/30/05 End: 04/30/07 Due: 04/30/08

Study of Silodosin to Facilitate Passage of Urinary Stones

Phase: N/A Priority: Normal
NCT ID: NCT01144949 Org: User:
Start: 06/30/10 End: 07/31/12 Due: 07/31/13

Effect of Two Iron Preparations on Protein in the Urine

Phase: N/A Priority: Normal
NCT ID: NCT00354692 Org: User:
Start: 06/30/06 End: - Due: -

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

Phase: N/A Priority: Normal
NCT ID: NCT00534144 Org: User:
Start: 09/30/07 End: 11/30/08 Due: 11/30/09

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Phase: N/A Priority: Normal
NCT ID: NCT01161563 Org: User:
Start: 07/31/10 End: 04/30/11 Due: 04/30/12

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00224120 Org: User:
Start: 05/31/05 End: 05/31/06 Due: 05/31/07

Dose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men

Phase: N/A Priority: Normal
NCT ID: NCT01104246 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11